Accuray Past Earnings Performance
Past criteria checks 0/6
Accuray's earnings have been declining at an average annual rate of -0.9%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 2.2% per year.
Key information
-0.9%
Earnings growth rate
1.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 2.2% |
| Return on equity | -30.5% |
| Net Margin | -3.3% |
| Next Earnings Update | 01 May 2024 |
Recent past performance updates
Recent updates
Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp
Apr 07Is Accuray (NASDAQ:ARAY) A Risky Investment?
Feb 03
Why Investors Shouldn't Be Surprised By Accuray Incorporated's (NASDAQ:ARAY) 26% Share Price Plunge
Aug 17These 4 Measures Indicate That Accuray (NASDAQ:ARAY) Is Using Debt Extensively
Apr 13The Return Trends At Accuray (NASDAQ:ARAY) Look Promising
Mar 14Accuray (NASDAQ:ARAY) Takes On Some Risk With Its Use Of Debt
Dec 01Accuray (NASDAQ:ARAY) Is Doing The Right Things To Multiply Its Share Price
Oct 27Accuray launches CyberKnife platform in Africa for cancer patients
Sep 30Accuray GAAP EPS of -$0.04 beats by $0.03, revenue of $110.02M beats by $4.7M
Aug 10Here's Why Accuray (NASDAQ:ARAY) Has A Meaningful Debt Burden
Jul 08Accuray (NASDAQ:ARAY) Might Have The Makings Of A Multi-Bagger
Jun 15Accuray: Nothing Special
May 31Accuray Once Again Hits The Reset Button On Its Progress
Feb 09A Look At The Fair Value Of Accuray Incorporated (NASDAQ:ARAY)
Jan 28Returns Are Gaining Momentum At Accuray (NASDAQ:ARAY)
Jan 08More Progress Evident At Accuray, But Sustainability And Follow-Through Remain Key
Nov 30Accuray (NASDAQ:ARAY) Is Looking To Continue Growing Its Returns On Capital
Sep 28Accuray: As Usual, Two Steps Forward, One-And-Three-Quarters Steps Back
Aug 20Should You Be Adding Accuray (NASDAQ:ARAY) To Your Watchlist Today?
Jun 16More 'Hurry Up And Wait' For Accuray, But The China Opportunity Is Coming Through
Jun 08We Like These Underlying Return On Capital Trends At Accuray (NASDAQ:ARAY)
May 31Accuray inks new $120M five-year revolving credit facility
May 07Revenue & Expenses BreakdownBeta
How Accuray makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 447 | -15 | 94 | 58 |
| 30 Sep 23 | 455 | -7 | 95 | 57 |
| 30 Jun 23 | 448 | -9 | 94 | 57 |
| 31 Mar 23 | 439 | -10 | 97 | 58 |
| 31 Dec 22 | 417 | -12 | 96 | 57 |
| 30 Sep 22 | 419 | -10 | 94 | 57 |
| 30 Jun 22 | 430 | -5 | 94 | 58 |
| 31 Mar 22 | 431 | -13 | 92 | 59 |
| 31 Dec 21 | 437 | -12 | 93 | 58 |
| 30 Sep 21 | 418 | -8 | 89 | 55 |
| 30 Jun 21 | 396 | -6 | 85 | 53 |
| 31 Mar 21 | 380 | 5 | 83 | 50 |
| 31 Dec 20 | 377 | 8 | 81 | 47 |
| 30 Sep 20 | 379 | 14 | 81 | 49 |
| 30 Jun 20 | 383 | 4 | 87 | 50 |
| 31 Mar 20 | 405 | 3 | 92 | 54 |
| 31 Dec 19 | 409 | -1 | 97 | 55 |
| 30 Sep 19 | 413 | -17 | 101 | 56 |
| 30 Jun 19 | 419 | -16 | 106 | 56 |
| 31 Mar 19 | 415 | -16 | 109 | 55 |
| 31 Dec 18 | 412 | -24 | 110 | 56 |
| 30 Sep 18 | 410 | -24 | 111 | 57 |
| 30 Jun 18 | 405 | -24 | 108 | 57 |
| 31 Mar 18 | 403 | -28 | 105 | 56 |
| 31 Dec 17 | 401 | -24 | 103 | 55 |
| 30 Sep 17 | 388 | -29 | 102 | 52 |
| 30 Jun 17 | 383 | -30 | 101 | 50 |
| 31 Mar 17 | 366 | -32 | 100 | 51 |
| 31 Dec 16 | 374 | -26 | 102 | 52 |
| 30 Sep 16 | 396 | -22 | 106 | 55 |
| 30 Jun 16 | 399 | -26 | 107 | 57 |
| 31 Mar 16 | 406 | -24 | 108 | 57 |
| 31 Dec 15 | 398 | -28 | 106 | 57 |
| 30 Sep 15 | 387 | -32 | 107 | 55 |
| 30 Jun 15 | 380 | -40 | 109 | 56 |
| 31 Mar 15 | 380 | -44 | 111 | 54 |
| 31 Dec 14 | 380 | -46 | 113 | 55 |
| 30 Sep 14 | 375 | -42 | 110 | 55 |
| 30 Jun 14 | 369 | -35 | 107 | 54 |
| 31 Mar 14 | 352 | -44 | 103 | 55 |
| 31 Dec 13 | 326 | -71 | 101 | 57 |
| 30 Sep 13 | 310 | -91 | 103 | 61 |
| 30 Jun 13 | 316 | -97 | 103 | 66 |
Quality Earnings: ARAY is currently unprofitable.
Growing Profit Margin: ARAY is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ARAY is unprofitable, and losses have increased over the past 5 years at a rate of 0.9% per year.
Accelerating Growth: Unable to compare ARAY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ARAY is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: ARAY has a negative Return on Equity (-30.53%), as it is currently unprofitable.